Surgery for Parkinson's disease.

Current pharmacological treatments for Parkinson's disease are not entirely adequate. A high proportion of patients chronically treated with levodopa and other dopaminergic drugs develop motor complications (fluctuations and dyskinesiae) and psychiatric complications.1 2 Additionally, some specific motor functions such as gait, balance, speech, deglutition, etc, become less responsive as disease and duration of treatment increase. It seems that both "non-physiological" dopaminergic stimulation and disease progression simultaneously interact to induce such complications.2 Xs a result, newer therapeutic avenues continue to be explored with two major aims: (1) to stop or slow down progression of disease and (2) to treat symptomatically the complications associated with chronic drug therapy. There has been a resurgence of interest in surgical treatments. Current stereotactic surgical techniques for Parkinson's disease include thalamotomy, pallidotomy, chronic intracerebral stimulation, or deep brain stimulation and striatal grafting of dopaminergic fetal tissue. Grafting is still under evaluation4 and is excluded from this review. The recent attention to surgical approaches has occurred as a result of several factors. Firstly, studies using the model of parkinsonism induced by 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine (MPTP), particularly in monkeys, have shown that hyperactivity in the subthalamic nucleus (STN) and medial globus pallidum (GPm) is a hallmark of the parkinsonian state and that lesions of these nuclei can reverse all the signs of experimental parkinsonism.6 Secondly, stereotactic surgery has become more precise and safer due to better stereotactic frames which provide high levels of mechanical accuracy, and to the development of high resolution brain CT and MRI. Finally, more refined electrophysiological techniques have allowed on line intraoperative assessment leading to precise recognition and mapping of the desired target and neighbouring structures-for example, the internal capsule or optic tract.

[1]  T. Ōkuma,et al.  Procaine oil blocking of the globus pallidus. , 1956, A.M.A. archives of neurology and psychiatry.

[2]  I. S. Cooper,et al.  Chemopallidectomy and chemothalamectomy. , 1958, Journal of neurosurgery.

[3]  I. S. Cooper,et al.  A CLINICAL AND RADIOLOGICAL CORRELATION OF THE LESIONS PRODUCED BY CHEMOPALLIDECTOMY AND THALAMECTOMY* , 1959, Journal of neurology, neurosurgery, and psychiatry.

[4]  L. Leksell,et al.  TREATMENT OF PARKINSONISM BY STEREOTACTIC THERMOLESIONS IN THE PALLIDAL REGION. A clinical evaluation of 81 cases. , 1960, Acta psychiatrica Scandinavica.

[5]  F. J. Gillingham,et al.  The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study. , 1980, Journal of neurosurgery.

[6]  S. Fahn Fluctuations of disability in Parkinson's disease: pathophysiology , 1981 .

[7]  J. D. Parkes,et al.  Fluctuations of disability in Parkinson's disease – clinical aspects , 1981 .

[8]  R. Wurtz,et al.  Visual and oculomotor functions of monkey substantia nigra pars reticulata. IV. Relation of substantia nigra to superior colliculus. , 1983, Journal of neurophysiology.

[9]  H. Narabayashi,et al.  Levodopa-induced dyskinesia and thalamotomy. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[10]  I. Mitchell,et al.  Regional brain uptake of 2-deoxyglucose in N -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—induced parkinsonism in the macaque monkey , 1985, Neuropharmacology.

[11]  L. Laitinen,et al.  Brain targets in surgery for Parkinson's disease. Results of a survey of neurosurgeons. , 1985, Journal of neurosurgery.

[12]  H. Wada,et al.  Further physiological observations on the ventralis intermedius neurons in the human thalamus. , 1989, Journal of neurophysiology.

[13]  I. Heuser,et al.  Rationale for continuous dopaminomimetic therapy of Parkinson's disease. , 1989, Neurology.

[14]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[15]  J A Obeso,et al.  Motor complications associated with chronic levodopa therapy in Parkinson's disease. , 1989, Neurology.

[16]  R. G. Robertson,et al.  Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 1989, Neuroscience.

[17]  M. Delong,et al.  Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.

[18]  H. Bergman,et al.  Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.

[19]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[20]  A. Benabid,et al.  Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus , 1991, The Lancet.

[21]  T. Aziz,et al.  Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate , 1991, Movement disorders : official journal of the Movement Disorder Society.

[22]  Richard S. J. Frackowiak,et al.  Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implants , 1992, Annals of neurology.

[23]  C. Marescaux,et al.  Contralateral disappearance of parkinsonian signs after subthalamic hematoma , 1992, Neurology.

[24]  R A Bakay,et al.  Posteroventral pallidotomy for Parkinson's disease. , 1992, Journal of neurosurgery.

[25]  J. Guieu,et al.  Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. , 1992, Journal of neurosurgery.

[26]  M. Hariz,et al.  Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. , 1992, Journal of neurosurgery.

[27]  M. Delong,et al.  Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. , 1992, Journal of neurophysiology.

[28]  A. Parent,et al.  Anatomical aspects of information processing in primate basal ganglia , 1993, Trends in Neurosciences.

[29]  J. Obeso,et al.  The subthalamic nucleus: A possible target for stereotaxic surgery in parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[30]  Common structural organization of two output nuclei of primate basal ganglia , 1993, Trends in Neurosciences.

[31]  M R DeLong,et al.  The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. , 1994, Journal of neurophysiology.

[32]  A. Korczyn,et al.  Persistent hemiballism in Parkinson's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[33]  H. Kwan,et al.  Single unit analysis of the human ventral thalamic nuclear group. Tremor-related activity in functionally identified cells. , 1994, Brain : a journal of neurology.

[34]  J. A. Obeso,et al.  Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease , 1994, The Lancet.

[35]  V. Kostic,et al.  Hemiballism: report of 25 cases. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[36]  A. Benabid,et al.  Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation , 1995, The Lancet.

[37]  O. Devinsky,et al.  Stereotactic ventral pallidotomy for Parkinson's disease , 1995, Neurology.

[38]  J. Bolam,et al.  Cholinergic, GABAergic, and glutamate-enriched inputs from the mesopontine tegmentum to the subthalamic nucleus in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  Scott T. Grafton,et al.  Pallidotomy increases activity of motor association cortex in parkinson's disease: A positron emission tomographic study , 1995, Annals of neurology.

[40]  J. Dostrovsky,et al.  Effect of GPi pallidotomy on motor function in Parkinson's disease , 1995, The Lancet.

[41]  R. Lonser,et al.  The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. , 1995, Neurosurgery.

[42]  P R Sanberg,et al.  Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. , 1995, The New England journal of medicine.

[43]  A L Benabid,et al.  Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients , 1996, Movement disorders : official journal of the Movement Disorder Society.

[44]  E. Hirsch,et al.  Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. , 1996, Brain : a journal of neurology.

[45]  Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. , 1996, Neurosurgery.

[46]  J. Obeso,et al.  Assessing the effects of pallidotomy in Parkinson's disease , 1996, The Lancet.

[47]  Absence of association between respiratory symptoms in young adults and use of gas stoves in Belgium , 1996, The Lancet.

[48]  Y. Agid,et al.  Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes , 1996, Neurology.

[49]  A. Benabid,et al.  Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. , 1996, Journal of neurosurgery.

[50]  Y. Agid,et al.  Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum , 1996, Neurology.

[51]  J. Sanes,et al.  Gamma knife pallidotomy in advanced parkinson's disease , 1996, Annals of neurology.

[52]  The pedunculopontine nucleus and related structures. Functional organization. , 1997, Advances in neurology.